Hydroxyurea
Who holds supplier records for Hydroxyurea? 4 organisations hold a current record for Hydroxyurea: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (2), China (1) and India (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Hydroxyurea: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/hydroxyurea
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Hydroxyurea expires 23 Dec 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Hydroxyurea. Country is the organisation's recorded country, not necessarily the manufacturing site.
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 11899, 37146 · latest filing Jun 2022
- ARCHIMICA SPAItalyCEP Company GMP cert on recordActive DMF 12754 · latest filing Nov 1997
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 20615 · latest filing Jun 2007
- BO-CHEM PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Hydroxyurea, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ARCHIMICA S.P.A Lodi | IT | CEP 2003-120 - Rev 04 Hydroxycarbamide | Jun 2026 | Inspected Feb 2026 Italy |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan | CN | CEP 2005-051 - Rev 05 Hydroxycarbamide | Sept 2025 | Inspected Sept 2023 Austria, outside 3-year window |
| BO-CHEM PRIVATE LIMITED Mumbai | IN | CEP 2024-209 - Rev 00 Hydroxycarbamide | May 2025 | — |
| OLON S.P.A. Rodano | IT | CEP 2022-263 - Rev 01 Hydroxycarbamide | Dec 2024 | Inspected Mar 2025 Italy |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Hydroxyurea are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- CHEMSPECInactive DMF 16458 · filed Feb 2003
- DSM PHARMA CHEMICALS SOUTH HAVEN INCInactive DMF 9850 · filed Sept 1992
- MEDEA RESEARCH LABORATORIES INCInactive DMF 9241 · filed Jul 1991
- BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTEInactive DMF 2452 · filed May 1975
- SQUIBBInactive DMF 2259 · filed Apr 1974
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (13 listed products contain Hydroxyurea). The latest listed patent expires 23 Dec 2041. The latest listed exclusivity runs to 4 Apr 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Hydroxyurea is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL467).
Chemical identity
- IUPAC name
- hydroxyurea
- Canonical SMILES
- C(=O)(N)NO
- InChIKey
- VSNHCAURESNICA-UHFFFAOYSA-N
- Synonyms
- Droxia, Hidroxicarbamida, Hydrea, Hydroxycarbamide, Hydroxyurea, NSC-32065, Siklos, SQ 1089, SQ-1089, Xromi, N-Hydroxyurea, Oxyurea
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Antimetabolite
- Chemical structure
- Urea
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Hydroxyurea?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Hydroxyurea: OLON SPA (Italy), ARCHIMICA SPA (Italy), Shandong Anxin Pharmaceutical Co., Ltd. (China) and BO-CHEM PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Hydroxyurea Drug Master Files are active?
OLON SPA (DMF 11899, 37146), ARCHIMICA SPA (DMF 12754) and Shandong Anxin Pharmaceutical Co., Ltd. (DMF 20615). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Hydroxyurea records mean?
5 organisations have only inactive Type II DMFs for Hydroxyurea. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Hydroxyurea have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Hydroxyurea on the EDQM register, including ARCHIMICA S.P.A Lodi (IT), SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan (CN), BO-CHEM PRIVATE LIMITED Mumbai (IN) and OLON S.P.A. Rodano (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Hydroxyurea?
Yes. The latest patent listed for an approved US product containing Hydroxyurea expires 23 Dec 2041, across 13 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Hydroxyurea supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Hydroxyurea?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.